The developing tooth is one of the classical model systems for studying the molecular mechanisms that † Institut fü r Sä ugetiergenetik GSF-Forschungszentrum fü r Umwelt und control organ development (reviewed by Thesleff and Nieminen, 1996; Thesleff et al., 1996) . The first morphoGesundheit 85764 Neuherberg logical manifestation of murine tooth development is a thickening of the oral ectoderm in prospective toothGermany forming regions of the mandibular and maxillary arches between embryonic day (E)11.5 (for molars) and E12 (for incisors) (Ruch, 1984) . This thickened ectoderm subseSummary quently invaginates into the underlying neural crestderived mesenchyme, which is proliferating and conVertebrate organogenesis is initiated at sites that are densing around the developing epithelial bud (E12-E13, often morphologically indistinguishable from the surbud stage). Ultimately, the ectoderm gives rise to the rounding region. Here we have identified Pax9 as a enamel secreting ameloblasts, and the mesenchyme to marker for prospective tooth mesenchyme prior to the dentine-secreting odontoblasts, pulp, and alveolar bone. first morphological manifestation of odontogenesis.
to any morphological manifestation of tooth developstage (late E10.5; 39 somites), prior to thickening of the dental ectoderm, Pax9 RNA is detected in a similar ment, and that induction of Pax9 expression in the mesenchyme is controlled by signals produced in the ectodistribution, but the level of Pax9 expression in prospective incisor mesenchyme is low; at that stage Pax9 RNA derm. Furthermore, we identify FGF8 as an ectodermal signal that induces Pax9 expression and show that is detected at even lower levels in the mesenchyme between the Pax9-positive prospective molar and inci-BMP2 and BMP4 function as antagonists of this inductive signal. Based on the data reported here, we propose sor domains (see Figure 3F ). At E10 to E10.5 (31-38 somites), only two lateral patches of Pax9-expressing that tooth formation is initiated at the appropriate sites in the mandibular arch not by a localized inducer, but cells are detected (Figures 1E and 2A) , which presumably mark the prospective sites of molar formation. The in response to a combination of two different signals produced in wide but overlapping domains.
earlier onset of Pax9 expression in the molar domains is consistent with studies demonstrating that initiation of molar development precedes that of the incisors (Ruch, Results 1984; Lumsden and Buchanan, 1986) , and the separation of the Pax9-positive prospective molar and incisor Pax9 Expression Is an Early Marker of Tooth Mesenchyme and Is Regulated by Signals mesenchyme by a region in which Pax9 is expressed at a lower level is consistent with morphological studies Produced in the Ectoderm Tooth development is arrested at the bud stage in Pax9-suggesting that molars and incisors develop from separate fields (Gaunt, 1964) . No Pax9 expression was dedeficient mice, indicating that Pax9 is required for tooth development at or before that stage (H. P. and R. B., tected in mandibular mesenchyme in embryos at early E10 (28 somites) or at earlier stages (data not shown). unpublished data). At E13.5, Pax9 RNA is detected at high levels in the mesenchymal cells surrounding the Thus it appears that the Pax9 expression that marks tooth mesenchyme at the bud stage is first induced at epithelial invaginations that constitute the tooth buds ( Figures 1A and 1B) . At E11.5 to E12.0, when the dental ‫ف‬E10 and therefore serves as a marker for the sites of tooth formation prior to any morphological manifestaectoderm has thickened and is just beginning to invaginate, Pax9 RNA is detected in the mesenchyme in four tion of this process. Analysis of E11.5 mandibular arch sections suggested domains that underlie the shallow depressions in mandibular ectoderm that mark the sites of odontogenesis.
that the highest level of Pax9 RNA is detected immediately adjacent to the ectoderm ( Figure 1C ). This observaThe two lateral and two medial Pax9-positive domains represent prospective molar and incisor mesenchyme, tion raised the possibility that Pax9 expression in the mesenchyme is induced and/or maintained by signals respectively (Figures 1C and 1D) . At a slightly earlier .5 embryos hybridized in whole mount with a digoxigenin-labeled Pax9 probe. The upper jaw and nose have been removed from the embryo shown in (D) to expose the mandibular arch. The dashed lines in (E) indicate cuts made in order to obtain explants of E9.5 and E10.5 mandibular arches. In addition to the Pax9 expression detected in prospective tooth mesenchyme, high levels of Pax9 RNA were also detected in the medial nasal processes. (F-J) Pax9 expression in cultured explants of the cranial half of the mandibular arch at E10.5. (F) Control explants with the overlying ectoderm intact; (G) mesenchyme without ectoderm; (H) mesenchyme cultured in contact with caudal mandibular arch (nondental) ectoderm; (I) mesenchyme cultured in contact with cranial mandibular arch ectoderm; (J) cranial mesenchyme and cranial mandibular ectoderm cultured on opposite sides of a 0.1 m pore size filter. (K) Expression of Pax9 in E11.5 prospective molar mesenchyme cultured for 24 hr in the absence of the overlying ectoderm. Abbreviations: ca, caudal; cr, cranial; de, thickened dental ectoderm; ecto, mandibular ectoderm; in, incisor primordium; ma, mandibular arch; mo, molar primordium; mnp, medial nasal process; mx, maxillary arch; te, tooth bud epithelium; tm, tooth mesenchyme. from the overlying dental ectoderm. To explore this possibility, we dissected the cranial half of the mandibular arch from embryos at E10.5 and cultured it in vitro (see Figure 1E and Experimental Procedures). Two domains of Pax9 expression were detected in these explants ( Figure 1F ). In contrast, when the ectoderm was removed prior to culture, no Pax9 RNA was detected in the explanted mesenchyme ( Figure 1G ). Likewise, mesenchyme explants cultured in the presence of nondental ectoderm (isolated from the caudal as opposed to the cranial half of the mandibular arch) did not express Pax9 ( Figure 1H ). However, Pax9 RNA was detected in cranial mandibular explants from which the ectoderm was removed and then replaced ( Figure 1I ). Similar results were obtained with explants isolated from embryos at E9.5, prior to the onset of Pax9 expression in mandibular mesenchyme (data not shown). These data indicate that the ability to induce and maintain Pax9 expression in the mesenchyme is restricted to the cranial mandibular ectoderm.
We next examined whether the induction/maintenance of Pax9 expression requires contact between the inducing ectoderm and the mesenchyme. Cranial mandibular ectoderm and mesenchyme isolated from E10.5 embryos were cultured on opposite sides of a membrane filter that either permits contact between the sep- Gel blue agarose marker bead soaked in PBS (blue circle) was implanted in the lateral region of the explant prior to culture. In (F), still required to maintain Pax9 expression in dental mesthe explants are oriented so that lateral is on the left. enchyme after E10.5, we assayed for Pax9 RNA in explants of E11.5 or E12.5 molar mesenchyme cultured for 24 hr without its overlying ectoderm. At the end of what is known about the tissue and stage-specificity of the culture period, Pax9 RNA was still readily detectable the diffusible signal that induces and maintains Pax9 in the isolated molar mesenchyme, albeit at a slightly expression in mandibular mesenchyme. As described reduced level as compared to the level in control exabove, Pax9 RNA is localized in two lateral domains plants cultured with ectoderm ( Figure 1K and data not corresponding to the prospective molar mesenchyme shown). Together, these data indicate that early expresat E10-E10.5 (Figure 2A ). At those stages, Fgf8 RNA is sion of Pax9 in mandibular mesenchyme is induced and detected in a domain within the ectoderm covering the maintained by a diffusible signal(s) from the overlying cranial but not the caudal half of the mandibular arch ectoderm, but that this signal is not required to maintain (data not shown). The Fgf8-expressing ectoderm was Pax9 expression after E11.5.
found to cover and extend medial and lateral to the Pax9 expression domain in the underlying mesenchyme Fgf8 Is Expressed in Cranial Mandibular Ectoderm, ( Figure 2B , compare with 2A). A similar pattern of Fgf8 and FGF Proteins Can Induce/Maintain Pax9 expression was detected in mandibular ectoderm at Expression in Mandibular Mesenchyme E9.5, before the onset of Pax9 expression in mandibular It has previously been reported that Fgf8 is expressed mesenchyme (data not shown). in mandibular ectoderm at ‫ف‬E10 (Heikinheimo et al., To determine whether FGF protein has an effect on 1994; Ohuchi et al., 1994; Crossley and Martin, 1995;  Pax9 expression, we isolated cranial mandibular mesen- Mahmood et al., 1995) , and FGF proteins are known to chyme from embryos at E9.5 (before Pax9 is normally induce the expression of various transcription factor expressed) and E10.5 and cultured it in contact with genes in other developmental settings (Niswander and heparin acrylic beads that had been soaked in FGF proMartin, 1993b; Schulte-Merker and Smith, 1995; Wang tein (FGF beads), PBS, or other growth factors. In exand Sassoon, 1995; Crossley et al., 1996a). We therefore plants cultured for 24 hr with FGF8 beads, Pax9 RNA sought to determine whether the spatio-temporal features of the Fgf8 expression pattern are consistent with was readily detected in a halo around the bead (n ϭ 9 at E9.5; n ϭ 9 at E10.5) ( Figure 2C and data not shown). after culture ( Figure 2E ). Pax9 RNA was detected in a halo around all FGF beads except those located in tissue Similar results were obtained with beads soaked in FGF2 (n ϭ 10) or FGF4 (n ϭ 15) (data not shown), consistent derived from the lateral margin of the mandibular arch ( Figure 2F and data not shown). These results show that with previous studies showing that these FGF proteins have the same biological activities as FGF8 in other in mandibular mesenchyme cultured in the absence of ectoderm, competence to express Pax9 in response to developmental contexts (Cohn et al., 1995; Crossley et al., 1996a Crossley et al., , 1996b Vogel et al., 1996) . In contrast, beads FGF is found in all but the lateral-most regions. soaked in PBS (n ϭ 12) ( Figure 2D ), BMP4 (n ϭ 11), IGF1 (n ϭ 6), SHH-N (n ϭ 5), or EGF (n ϭ 9) did not induce Bmp2 and Bmp4 Are Expressed in Regions of the Mandibular Arch in Which Pax9 expression in mandibular mesenchyme (see Figure  4F and data not shown). Together these data show that Pax9 Is Not Expressed The observations that competence to express Pax9 in FGF proteins, including FGF8, are sufficient to induce and maintain Pax9 expression in mandibular mesenresponse to an FGF signal is widespread in mesenchyme cultured without ectoderm and that the Fgf8 chyme, and that the Fgf8 gene is expressed in ectoderm that produces the Pax9-inductive signal.
expression domain in the mandibular ectoderm is more extensive than the Pax9 expression domains in underlying mesenchyme raise the possibility that a second Competence to Express Pax9 in Response to an FGF Signal Is Widespread in signal restricts Pax9 expression. Members of the BMP subfamily related to Drosophila decapentaplegic (BMP2 Mandibular Mesenchyme In the experiments described above, a single bead that and BMP4) are good candidates for such a signal, since BMP2 and BMP4 can antagonize FGF function in the had been soaked in FGF2, FGF4, or FGF8 was placed near the middle of the explant. Pax9 RNA was detected developing mouse limb bud Martin, 1993a, 1993b) . Moreover, BMP2 and BMP4 are known in a halo around the bead in most explants, but in some cases Pax9 RNA was detected on only one side of the to be expressed in the mandibular arch (Lyons et al., 1990; Jones et al., 1991) . We therefore sought to deterbead. These observations suggested that competence to express Pax9 in response to an FGF signal is widemine whether Bmp2 or Bmp4 is expressed in patterns consistent with a potential function as an inhibitor of spread but not ubiquitous in mandibular mesenchyme. In order to better define the extent of such competence, Pax9 expression in the mandibular arch. At E10.0 (32-34 somites), Bmp4 RNA is detected in individual explants isolated at E10.5 were cultured with multiple FGF beads. In some explants, the lateral region ectoderm overlying the distal-medial region of the mandibular arch, between the two Pax9 expression domains of the mandibular arch was marked with a PBS-soaked Affi-Gel blue agarose bead so that it could be identified representing prospective molar mesenchyme, but not Figures 3C and 3D ). At E10.5 (39-40 somites), Pax9 RNA is detected in the prospective molar Pax9 Expression To determine whether BMP2 and BMP4 proteins can mesenchyme and also at relatively low levels in two new domains representing prospective incisor mesenchyme inhibit Pax9 expression in the mandibular arch, we prepared E10.5 cranial mandibular explants and placed ( Figures 3F and 3I ). Bmp4 RNA is still detected in the ectoderm overlying the medial region in which tooth them intact (i.e. with ectoderm in place) on top of several beads soaked in BMP2 or BMP4 to ensure that the development will not occur ( Figure 3G ), and more laterally, Bmp4 RNA is now detected in a spur that extends mesenchyme was exposed to BMP protein during the culture period. In explants cultured in contact with PBS further proximal than the rest of the Bmp4 expression domain (arrowheads in Figure 3G ). This spur of Bmp4-beads (n ϭ 6), Pax9 RNA was detected at the same level and in the same pattern as in explants cultured without expressing ectoderm overlies the region between the Pax9-positive prospective incisor and molar mesenbeads ( Figure 4A and data not shown), whereas little or no Pax9 RNA was detected after 24-48 hr of culture chyme in which Pax9 RNA is detected at lower levels, especially near the ectoderm. Although this spatial relawith BMP4 beads (n ϭ 5) or BMP2 beads (n ϭ 4) ( Figure  4B and data not shown). In contrast, when E10.5 mantionship of the expression domains was difficult to visualize in whole-mount preparations (compare Figures dibular mesenchyme was cultured with a BMP4 bead and analyzed with a probe for Msx1 instead of Pax9, 3F and 3G), it was readily visible when sections of the region were analyzed (compare Figures 3I and 3J ). Thus, Msx1 RNA was detected at high levels in cells surrounding the bead (n ϭ 10/11 explants assayed; data Bmp4 is expressed in the ectoderm in regions of the mandibular arch in which Pax9 RNA is not detected or not shown). These results argue against the possibility that the BMP-soaked beads prevent gene expression is present at low levels in the underlying mesenchyme.
Bmp2 RNA was detected at the 33-and 39-somite in some nonspecific way; for example, by causing a high rate of cell death. Interestingly, when explants isolated stages only after prolonged staining, at low levels in the lateral region of the cranial mandibular arch flanking the from embryos at late E11.5 and E12.5 were cultured with multiple BMP beads, there was little effect on Pax9 Pax9-expressing molar mesenchyme (compare Figures  3B and 2A) . Analysis of sectioned samples suggests expression (n ϭ 5 for late E11.5; n ϭ 5 for E12.5) ( Figure  4C and data not shown). These data show that BMP that Bmp2 expression is restricted to the mesenchyme (data not shown).
protein can specifically inhibit Pax9 expression in mandibular mesenchyme at early stages when it is regulated A comparison of their expression patterns indicates that Bmp2/Bmp4 and Fgf8 are expressed in wide but by signals from cranial mandibular ectoderm, but not at later stages, when ectoderm-derived signals are no overlapping domains, and that Pax9 is not expressed in regions in which Bmp2 or Bmp4 is also detectable.
longer required to maintain Pax9 expression. Since our data have provided strong evidence that Specifically, in the lateral region of the mandibular arch, Bmp2 and Fgf8 are coexpressed, and Pax9 expression Fgf8 expressed in the cranial mandibular ectoderm is the signal that induces and maintains Pax9 expression is not detected (compare Figures 2A, 2B , and 3B). In the medial region, Bmp4 is widely expressed, and Fgf8 in the underlying mesenchyme and that BMPs can antagonize Pax9 induction by signals from the cranial manis coexpressed in the ectoderm at the lateral margins of this Bmp4 domain; however, Pax9 RNA is not detected in dibular ectoderm, we next sought to determine directly whether BMPs can prevent the induction of Pax9 exthis region ( Figures 3C-3E ), even though data from our explant studies indicate that this mesenchyme is compression by FGF protein. E10.5 cranial mandibular mesenchyme was cultured in combination with both FGFpetent to express Pax9 in response to FGF. Likewise, Bmp4 and Fgf8 are also coexpressed in the ectoderm (FGF4 or FGF8) and BMP-(BMP2 or BMP4) soaked beads. In control cultures, in which the explants were that overlies the region of weak Pax9 expression between the sites of prospective incisor and molar develexposed to a single FGF and two PBS beads, Pax9 expression was detected in a halo surrounding the FGF opment ( Figures 3I-3K ). These data are consistent with a role for BMP proteins as antagonists of FGF-mediated bead, indicating that the presence of the PBS beads had no effect (n ϭ 5) ( Figure 4D ). In contrast, when the induction of Pax9 expression. bead was flanked by two BMP beads, the Pax9 expression domain around the FGF bead was interrupted by Pax9-negative regions in the vicinity of the BMP beads (n ϭ 26) ( Figure 4E and data not shown). The shape of the Pax9 expression domain was dependent on the position of the two BMP beads: when they were placed on opposite sides of the FGF bead, Pax9 RNA was detected in two small domains equidistant from the two BMP beads and close to the FGF bead; when they were placed on the same side, Pax9 RNA was detected in a semicircle on the side opposite the BMP beads. No a signal from the oral ectoderm (Mina and Kollar, 1987; Lumsden, 1988) . Because thickening of the prospective dental ectoderm is the first visible manifestation of tooth incisor development ( Figure 5C ). According to this hydevelopment, and because it occurs prior to any obvious pothesis, dental ectoderm thickening occurs only after changes in the mesenchyme, it has been assumed that specification of tooth mesenchyme has been initiated, the thickened dental ectoderm is the source of the signal suggesting that the signal for initiation of tooth developthat initiates odontogenesis in the mesenchyme. In this ment in the ectoderm might come from the prospective study we have identified Pax9 as a marker for the sites tooth mesenchyme. Alternatively, the same signals that of prospective odontogenesis and have shown that its specify the molar and incisor fields in the mesenchyme expression in mandibular mesenchyme is induced and could also act in the ectoderm to define the region that maintained by a diffusible signal from cranial mandibular is to thicken and subsequently produce signals that ectoderm prior to thickening of the dental ectoderm.
promote further specification of the tooth mesenchyme. Furthermore, we show that Fgf8 is expressed in a wide
In the mouse, three teeth ultimately form in the molar domain in the mandibular ectoderm, including the region field; development of the second and third molars beoverlying Pax9-positive mesenchyme, at the right time gins at ‫ف‬E15 and ‫01ف‬ days postnatal, respectively to serve as this inducer, and that FGF8 protein is suffi- (Gaunt, 1964) . It is possible that the initiation of their cient to induce Pax9 expression. We also demonstrate development late in embryogenesis and postnatally may that competence to express Pax9 in response to FGF also be controlled by FGF and BMP signaling, but the is relatively widespread in the mesenchyme, suggesting studies described here do not address this issue. Likethat a second signal may antagonize the inductive signal wise, our studies do not address the question of how and thereby restrict the domains of Pax9 expression.
the molar and incisor fields in the upper jaw are speciWe show that Bmp2 and Bmp4 are expressed at the fied, but based on our preliminary analysis of gene exright time and place for their products to serve as such pression patterns it seems likely that the mechanism is an antagonist. Finally, using a tissue explant assay, we the same as that used in the lower jaw. Although the demonstrate that BMP2 and BMP4 can antagonize the model described here for the specification of the molar inductive effects of FGF on Pax9 expression. and incisor fields may be simplistic, it provides a frameThese data suggest the following model for the speciwork for further experimental studies that may ultimately fication of the molar and incisor fields: at E10-10.5, prior lead to a more comprehensive understanding of the to thickening of the dental ectoderm, FGF8, produced mechanism of tooth development. by cranial mandibular ectoderm, functions as an inducer of tooth development in the underlying mesenchyme. BMP4 and BMP2 produced by the ectoderm and/or the The Roles of FGF8 and PAX9 in Tooth Development Fgf8 is presently the only FGF family member known to mesenchyme function as antagonists of the FGF signal and inhibit tooth development. Therefore, odontogenbe expressed in prospective dental ectoderm. Our data provide evidence that it functions prior to the first moresis is initiated only in regions in which the inducer (FGF) is present, its antagonist (BMP) is absent, and the phological manifestation of tooth development, as an ectodermal signal that induces Pax9 expression in the mesenchyme is competent to respond to the inducer ( Figure 5A ). At E10, these conditions are met only in the underlying mesenchyme. Since Pax9 function is required for tooth development beyond the bud stage region of prospective molar development ( Figure 5B) ; at E10.5, presumably due to subtle changes in the (H. P. and R. B., unpublished data), FGF8 appears to be a key inductive signal for odontogenesis. Previous boundaries of the expression domains of Fgf8 and Bmp4, they are also met in the region of prospective studies have suggested that FGFs also function at later stages of tooth development to stimulate cell prolifera- (Means and Gudas, 1996) . However, in other developmental contexts the FGF and BMP signaling systems tion, prevent apoptosis, and influence gene expression in the early dental mesenchyme (Chen et al., 1996; Thes- appear to act synergistically: a combination of BMP2 and FGF4, but neither factor alone, induces cardiogenleff and Sahlberg, 1996) . Our data add to the growing evidence that FGF8 functions as an inductive signal in esis in explants of mesoderm that does not normally contribute to the heart primordium (Lough et al., 1996) . a variety of developmental settings. For example, FGF8 appears to play a key role in both the induction and
In addition, during gastrulation in Xenopus, BMP4 lowers the amount of FGF required to induce the expression maintenance of limb development. Implantation of an FGF bead in the interlimb region induces Fgf8 expresof the mesodermal markers Xcad-3 and Xbra (Northrop et al., 1995) . sion in the overlying ectoderm and results in the development of an ectopic limb. Once the limb bud is estabOur data have identified BMP as an antagonist of FGFmediated induction of Pax9 during the early stages of lished, FGFs produced in the apical ectodermal ridge (AER), including FGF8, maintain outgrowth and patodontogenesis. However, we made one observation that might appear inconsistent with this conclusion: in externing of the limb (Niswander et al., 1993; Fallon et al., 1994; Crossley et al., 1996b; Vogel et al., 1996) . In the plants at E10.5, competence to express Pax9 in response to FGF was found to be widespread in medial brain, FGF8 is produced in a signaling center at the mid/ hindbrain boundary, the isthmic organizer, and appears mesenchyme ( Figure 2E ), yet analysis of E10.5 embryo sections revealed that some of the mesenchyme in this to play a role in patterning the midbrain (Crossley et al., 1996a; Lee et al., 1997) . Thus, implantation of FGF8 competent region expresses Bmp4 (data not shown).
One possible explanation for this apparent contradiction beads in the caudal diencephalon results in the induction of Fgf8 expression in cells around the bead and is that Bmp4 expression might not be maintained when the ectoderm is removed, and isolated mesenchyme is leads to the formation of an ectopic isthmus-like signaling center, which functions to repattern the surrounding assayed for competence. This proved to be the case: no Bmp4 RNA was detected when mandibular mestissue and results in the development of an ectopic midbrain.
enchyme was cultured in the absence of ectoderm, whereas Bmp4 RNA was readily detectable in explants The function of Pax9 in the dental mesenchyme remains to be determined. However, since it is a member cultured with ectoderm (data not shown). Therefore, removal of the ectoderm results in a loss of Bmp4 expresof the paired-box transcription factor gene family, which plays key roles at early stages in the development of sion in the mesenchyme, which apparently renders it competent to express Pax9 in response to FGF. Thus many organs (reviewed by Wehr and Gruss, 1996) , Pax9 is likely to play a role in specifying mandibular arch cells all of our data are consistent with the hypothesis that BMPs function to inhibit the induction of Pax9, thereby as prospective tooth mesenchyme. In Pax9-deficient embryos, tooth development is arrested at the bud localizing the sites of Pax9 expression in the mandibular arch mesenchyme. stage, when tooth mesenchyme in normal embryos produces signals that are required for further development
In the future, it will be important to determine precisely how BMPs interfere with FGF-mediated induction and of the dental ectoderm (Kollar and Baird, 1970; Mina and Kollar, 1987) . Although Pax9 expression is initiated maintenance of Pax9 expression. Although it is possible that inhibition of Pax9 expression by BMPs does not prior to the thickening of the dental ectoderm, it cannot be required to induce either thickening or subsequent involve the FGF-signaling pathway, this seems unlikely since BMP protein does not inhibit Pax9 expression at downgrowth of the tooth epithelium, since those processes appear to occur normally in Pax9-deficient em-E11.5, after it has become independent of FGF signaling. Another possibility is that BMP directly or indirectly bryos. However, Pax9 function might be required to establish the competence of prospective tooth mesenblocks reception of the FGF signal, but as yet there is no evidence that BMPs can interfere with FGF binding chyme to respond to signals from the thickened dental ectoderm, and in the absence of this competence the to its receptor. Thus a more likely possibility is that BMP signaling interferes with the transduction of the FGF tooth mesenchyme may be incapable of producing the signals required to direct subsequent epithelial morphosignal.
Interestingly, BMP4 appears to have a very different genesis. Alternatively, Pax9 may play a more direct role function in odontogenesis after Pax9 expression has in regulating the production of signaling molecules by been induced in the mesenchyme, and the dental ectothe mesenchyme.
derm has thickened. At E11.5, BMP4 is transiently expressed in the thickened dental ectoderm, and local BMPs as Antagonists of FGF Signaling application of beads soaked in BMP4 or BMP2 to exPrevious studies have provided evidence for interacplants of E11.5 dental mesenchyme mimics many of tions between the FGF and BMP signaling systems. In the inductive effects of the dental ectoderm, including the limb, FGF and BMP appear to function antagonististimulation of the expression of Msx1, Msx2, Egr1, Lef1, cally: FGFs stimulate outgrowth and also induce the and of Bmp4 itself in the underlying mesenchyme (Vainio expression of Evx1, a homeobox gene related to Droet al., 1993; Chen et al., 1996; Kratochwil et al., 1996) , sophila even-skipped, in limb bud explants, and BMP2 resulting in coexpression of Bmp4 and Pax9 in dental inhibits these activities (Niswander and Martin, 1993a, mesenchyme. The latter observation is consistent with 1993b). Antagonistic interactions between FGF and our finding that BMP4 does not prevent Pax9 expression BMP also regulate the amount of cellular retinoic acid after E11.5. Thus, early in tooth development BMP4 functions as an inhibitor of odontogenesis, and later it binding protein RNA produced in BALB 3T3 fibroblasts (Kaufman, 1994) . All dissections were performed in cold L15 mandibular arch. The expression of signaling molecules medium (GIBCO-BRL) using electrolytically sharpened tungsten is thought to be induced at boundaries between differneedles. To obtain tissue for explant culture from embryos at stages ently specified territories, such as the anterior-posterior between E9.5 and E10.5, the mandibular arch was first cut in the transverse plane to divide it in into cranial and caudal portions, and or dorsal-ventral boundaries of the wing imaginal disc these were then cut into left and right halves (see Figure 1E ). Exin Drosophila, or the dorsal-ventral boundary in proplants containing the molar-forming regions, which were identified spective limb ectoderm in vertebrates (Meinhardt, 1983) .
by virtue of shallow depressions in the overlying ectoderm, were
The epithelium covering the mandibular arch is comisolated from E11.5 and E12.5 embryos. All explants were cultured posed of cells of two different lineages, the ectoderm on nucleopore filters (8 m pore size, Costar) floating on culture that lines the primitive mouth and participates in tooth medium (Dulbecco's minimal essential medium supplemented with 10% FCS, penicillin, and streptomycin). After 24-48 hr of culture, development (discussed by Lumsden, 1988) , and the the explants were fixed and processed for whole-mount in situ hyendoderm at the anterior end of the foregut (the pro- expressed.
Protein-soaked beads were stored at 4ЊC for up to 3 weeks. Prior to use, all beads were washed in a drop of culture medium. Transfilter culture experiments were performed as described by Thesleff et al. (1977) , using Nucleopore filters with 0.1 m or 8 m pores.
Concluding Remarks
Although in some cases genes required to initiate the development of a specific organ have been identified,
RNA in Situ Hybridization
little is known about how their expression is induced For RNA in situ hybridization analysis of paraffin sections (5 m), at the appropriate site. An obvious possibility is that embryos were processed, sectioned, and hybridized with digoxigenin-labeled riboprobes as described by Neubü ser et al. (1995) a single inducer (or competence factor) expressed at with some modifications (A. N. and R. B., unpublished data). For exactly the right place is involved in restricting gene whole-mount RNA in situ hybridization, embryos or explants were expression. Here we provide evidence that at a stage fixed, processed, and hybridized according to the protocol dewhen there are no morphological cues as to the proscribed by Henrique et al. (1995) . Digoxigenin-labeled antisense spective sites of tooth formation, gene expression esriboprobes were detected with alkaline phosphatase-coupled antisential for tooth development is induced at specific sites digoxigenin antibodies using BM purple (Boehringer Mannheim) as the color substrate. The plasmids used to prepare the antisense not by a single signaling molecule produced at those riboprobes used in this study were previously described: Pax9 (Neusites, but by the combined activity of two different sigbü ser et al., 1995); Fgf8 (Crossley and Martin, 1995) ; Bmp2 and nals expressed in wide but overlapping domains. One
Bmp4 (Wozney et al., 1988 , kindly provided by Genetics Institute).
(FGF8) induces gene expression, and the other (BMP2 and BMP4) prevents this induction. Given the remark-
